Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
ACS Chem Neurosci. 2013 Apr 17;4(4):519-26. doi: 10.1021/cn300191b. Epub 2013 Feb 4.
Brain diseases are notoriously difficult to treat due to the presence of the blood-brain barrier (BBB). Here, we review the development of focused ultrasound (FUS) as a noninvasive method for BBB disruption, aiding in drug delivery to the brain. FUS can be applied through the skull to a targeted region in the brain. When combined with microbubbles, FUS causes localized and reversible disruption of the BBB. The cellular mechanisms of BBB disruption are presented. Several therapeutic agents have been delivered to the brain resulting in significant improvements in pathology in models of glioblastoma and Alzheimer's disease. The requirements for clinical translation of FUS will be discussed.
脑部疾病由于血脑屏障(BBB)的存在而难以治疗。在这里,我们回顾了聚焦超声(FUS)作为一种非侵入性的 BBB 破坏方法的发展,有助于将药物递送到大脑。FUS 可以通过颅骨应用于大脑中的靶向区域。当与微泡结合时,FUS 会导致 BBB 的局部和可逆性破坏。介绍了 BBB 破坏的细胞机制。已经将几种治疗剂递送到大脑中,导致胶质母细胞瘤和阿尔茨海默病模型中的病理显著改善。将讨论 FUS 临床转化的要求。
ACS Chem Neurosci. 2013-2-4
Expert Opin Drug Deliv. 2014-3-20
Int J Hyperthermia. 2012
Proc Natl Acad Sci U S A. 2020-4-13
Expert Opin Drug Deliv. 2013-4-4
Proc Natl Acad Sci U S A. 2021-9-14
Drug Deliv Transl Res. 2025-8-11
J Nanobiotechnology. 2025-7-30
Small Sci. 2024-3-19
Biomedicines. 2024-12-22
Theranostics. 2024
Int J Mol Sci. 2024-6-18
Pharmaceutics. 2023-11-7
Cancer Res. 2013-1-9
J Cereb Blood Flow Metab. 2012-8-29
J Control Release. 2012-8-19
Int J Hyperthermia. 2012